businesspress24.com - Mirada Medical Software Selected for Tumor Metrics at MD Anderson Cancer Center
 

Mirada Medical Software Selected for Tumor Metrics at MD Anderson Cancer Center

ID: 1059740

(firmenpresse) - OXFORD, UK -- (Marketwire) -- 11/23/11 -- Mirada Medical announced that it has been selected to deliver its advanced XD3 image review and analysis software to The University of Texas MD Anderson Cancer Center in Houston. Mirada's latest XD3 software release includes volumetric CT segmentation in addition to tools for CT/PET and MR/PET to facilitate both anatomical and functional response tracking.

Mirada XD3 provides powerful tools and efficient workflows for quantification and tracking of findings in an unlimited number of studies for all major modalities including CT, MR, CT/PET and MR/PET.



Mirada Medical is an internationally recognised brand in advanced medical imaging. The company develops high value clinical software applications, which are used across diagnostic radiology, nuclear medicine, radiation oncology, tumor board and elsewhere.

Mirada specializes in simplifying technically complex image processing tasks, allowing clinicians to more confidently diagnose disease, assess response to treatment and plan radiation therapy or surgical intervention.

Mirada was originally spun out of the University of Oxford. The company's technologies are, to this day, developed by a team of dedicated engineers and world-renowned scientists working out of Oxford, England.

Mirada's products have been designed to ease the deployment of these powerful technologies into any hospital or imaging center workflow. Mirada's applications can be delivered using thin client or cloud based architectures, or licensed on a floating or per workstation basis. Most recently, Mirada has focused on the development of disease specific solutions for use across departments working with patients to fight cancer. In particular, Mirada's powerful image registration technologies have been tuned to the needs of radiation oncology, and quantification technologies have been redefined to optimize support for standard protocols such as RECIST and PERCIST. In addition, powerful imaging solutions have been introduced to support better collaborative working, in particular in the context of a rich web-based viewer for referring physicians and a robust solution for presentation of images at multidisciplinary meetings such as tumor board.







For more information,







US/Worldwide: Robert Ripley
tel: (440) 591-8638
Insource Communications




Oxford Center for Innovation
New Road, Oxford
OX1 1BY
United Kingdom
Tel: +44(0)1865 261410


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Response Biomedical Corporation Announces Debt Financing
Mirada Medical Makes Bold Challenge at RSNA, Brings MR/PET to Everyone
Bereitgestellt von Benutzer: MARKET WIRE
Datum: 23.11.2011 - 02:12 Uhr
Sprache: Deutsch
News-ID 1059740
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

OXFORD, UK


Phone:

Kategorie:

Alternative


Anmerkungen:


Diese Pressemitteilung wurde bisher 128 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Mirada Medical Software Selected for Tumor Metrics at MD Anderson Cancer Center
"
steht unter der journalistisch-redaktionellen Verantwortung von

Mirada Medical (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Mirada Medical



 

Who is online

All members: 10 566
Register today: 1
Register yesterday: 0
Members online: 0
Guests online: 83


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.